Using Mobile Health (mHealth) to Improve STI Treatment Adherence Among Adolescents

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age15-21
SponsorChildren's National Research Institute

About this trial

We will conduct a randomized trial to compare differences in sexually transmitted infection (STI) treatment adherence between patients receiving text messages versus those receiving usual care (e.g. no text messages). We hypothesize that STI treatment adherence will be 20% higher among patients randomized to receipt of two-way text messaging services.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Adolescent patients seen in the Emergency Department who test positive for gonorrhea, chlamydia, or pelvic inflammatory disease and are prescribed outpatient antibiotic treatment.

Disqualifiers

Patients will be excluded if they are unable to understand English, are critically ill, have cognitive impairment or if they do not have access to a cellular telephone with text messaging capabilities.

Trial design

Design model

Single group

Treatments tested in this trial

  • mHealth Intervention

    Behavioral

    Adolescents will receive text messages to facilitate treatment adherence

Treatment groups

270 Participants
are divided into 2 treatment groups
Group A: mHealthOther 1 intervention
Group B: Usual careNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

STI treatment adherence

Proportion of study participants who complete their medication as prescribed by self-report

Time frame
1-21 days after prescription filling

Secondary outcomes

1

STI treatment receipt

Proportion of study participants who receive STI treatment; measured by prescription filling and/or receiving treatment at a healthcare facility

Time frame
1-21 days after STI diagnosis

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.